world
6 known investors
ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs. The company is focused on rare genetic conditions including cystic fibrosis and primary ciliary dyskinesia.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
DD
Dr. Daniel J. Siegwart
Investors · 6
In the news
- Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · 2026
- Seeds | Jumps to World Model Unicorn in One Year! Manifold AI Raises Hundreds of Millions in New Funding | Gasgooautonews.gasgoo.com · 2026
- Fei-Fei Li's World Labs Raises $1B in Fresh Funding to Advance Development of World Modelstheaiinsider.tech · 2026